{"database": "lobbying", "table": "lobbying_activities", "rows": [[1114576, "37a1d51e-33c8-47fc-b7e7-ccfd9191f932", "Q2", "CEPHEID", 400270233, "CEPHEID", 2011, "second_quarter", "MED", "See page five Lobbying Issues: molecular diagnostic tests, infection control and prevention programs (Multidrug resistant organisms (MDRO)), CDC-related issues (MDRO research and surveillance), hospital and other provider quality improvement programs\nCMS-related issues (reimbursement and coverage policies), FDA oversight, global health funding\ncomparative effectiveness, personalized medicine/pharmacogenomics, Veterans Affairs healthcare-related issues\nHR 436/ S 17, Protect Medical Innovation Act of 2011\nHR 488, Save Our Medical Devices Act of 2011\nHR 755, Investing in Our Future Act of 2011\nHR 965/ S 1211, Preservation of Antibiotics for Medical Treatment Act of 2011\nHR 2182 Generating Antibiotic Incentives Now (GAIN)\nS 660, Preserving Access to Targeted, Individualized, and Effective New Treatments and Services (PATIENTS) Act of 2011", "Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),SENATE", null, 30000, 0, 0, "2011-07-15T15:47:01.777000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1114576"], "units": {}, "query_ms": 0.2930319169536233, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}